MedPath

The effect of Lidocaine on control of emergence agitation due to Sevoflurane

Phase 3
Conditions
Agitation.
Restlessness and agitation
Registration Number
IRCT2013072914199N1
Lead Sponsor
Research Council of Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Parent willingness to participate in the study and informed consent, Age group: 12 to 36 months, Retinoblastoma eyes Exclusion criteria: A history of seizures, Liver disease, Kidney disease, Heart disease, Having a cold during the current week, Sensitivity to Lidocaine, Intense crying

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Agitation. Timepoint: The scores were recorded every 10 minutes (In the first 30 minutes after entering into recovery), since the children transferred to recovery. Method of measurement: Anesthesiologist divided children into 5 levels based on agitation: 1. Asleep; 2. Awake and calm; 3. Irritable or consolable crying; 4. Inconsolable crying; and 5. Severe restlessness.
Secondary Outcome Measures
NameTimeMethod
ausea and vomiting. Timepoint: The symptoms were recorded every 10 minutes (In the first 30 minutes after entering into recovery), since the children transferred to recovery. Method of measurement: Observation.
© Copyright 2025. All Rights Reserved by MedPath